Physiological modeling for technical, clinical and research applications.

Front Biosci (Schol Ed)

ErgonSim, Comfort Energy Efficiency, Holderbuschweg 47, D-7056 Stuttgart, Germany.

Published: June 2010

Various and disparate technical disciplines have identified a growing need for tools to predict human thermal and thermoregulatory responses to environmental heating and cooling and other thermal challenges such as anesthesia and non-ionizing radiation. In this contribution, a dynamic simulation model is presented and used to predict human thermophysiological and perceptual responses for different applications and situations. The multi-segmental, multi-layered mathematical model predicts body temperatures, thermoregulatory responses, and components of the environmental heat exchange in cold, moderate, as well as hot stress conditions. The incorporated comfort model uses physiological states of the human body to predict thermal sensation responses to steady state and transient conditions. Different validation studies involving climate-chamber physiological and thermal comfort experiments, exposures to uncontrolled outdoor weather conditions, extreme climatic and radiation asymmetry scenarios revealed the model to predict physiological and perceptual responses typically within the standard deviation of the experimental observations. Applications of the model in biometeorology, clothing research, the car industry, clinical and safety applications are presented and discussed.

Download full-text PDF

Source
http://dx.doi.org/10.2741/s112DOI Listing

Publication Analysis

Top Keywords

predict human
8
thermoregulatory responses
8
perceptual responses
8
responses
5
model
5
physiological
4
physiological modeling
4
modeling technical
4
technical clinical
4
applications
4

Similar Publications

BACKGROUND This study aimed to analyze the risk factors of central nervous system (CNS) infection caused by reactivation of varicella zoster virus (VZV) and provide reference for the prevention and early diagnosis of VZV-associated CNS infection. MATERIAL AND METHODS A prospective study was conducted on 1030 patients with acute herpes zoster (HZ) admitted to our hospital from January 2021 to June 2023. According to clinical manifestations and auxiliary examinations, they were divided into HZ group of 990 patients and VZV-associated CNS infection group of 40 patients.

View Article and Find Full Text PDF

COVID-19 is a trigger of autoimmune rheumatic diseases: a hypothesis tested over time.

Rheumatol Int

December 2024

Department of General Practice N2, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.

We discuss the paper recently published in Rheumatology Internationa. This article reflects on the prevalence of autoimmune rheumatic diseases (ARD) during the COVID-19 pandemic (2020-2023) and compares the same with the pre-pandemic period (2016-2019). We assume that SARS-CoV-2 triggers ARD.

View Article and Find Full Text PDF

This study explored the early diagnosis and prognostic value of copeptin in non-ST-segment elevation acute coronary syndrome (NSTE-ACS). 171 patients with chest pain or myocardial ischemia symptoms were enrolled. Patients with NSTE-ACS were further divided into the non-ST-elevation myocardial infarction (NSTEMI) and unstable angina (UA).

View Article and Find Full Text PDF

Impaired nutritional status is closely related to the development of sarcopenia and poor quality of life (QoL) in cancer patients. This study aimed to investigate the association of Geriatric Nutritional Risk Index (GNRI) with sarcopenia and QoL in patients with gastric cancer (GC). Sarcopenia was diagnosed based on the Asian Working Group for Sarcopenia 2019 criteria.

View Article and Find Full Text PDF

Optimizing T cell inflamed signature through a combination biomarker approach for predicting immunotherapy response in NSCLC.

Sci Rep

December 2024

Interventional Oncology, Johnson & Johnson Enterprise Innovation, Inc, 10th Floor 255 Main St, 02142, Cambridge, Boston, MA, USA.

The introduction of anti-PD-1/PD-L1 therapies revolutionized treatment for advanced non-small cell lung cancer (NSCLC), yet response rates remain modest, underscoring the need for predictive biomarkers. While a T cell inflamed gene expression profile (GEP) has predicted anti-PD-1 response in various cancers, it failed in a large NSCLC cohort from the Stand Up To Cancer-Mark (SU2C-MARK) Foundation. Re-analysis revealed that while the T cell inflamed GEP alone was not predictive, its performance improved significantly when combined with gene signatures of myeloid cell markers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!